These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31355309)

  • 1. CSF parameters associated with early MRI activity in patients with MS.
    Klein A; Selter RC; Hapfelmeier A; Berthele A; Müller-Myhsok B; Pongratz V; Gasperi C; Zimmer C; Mühlau M; Hemmer B
    Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e573. PubMed ID: 31355309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
    Pfuhl C; Grittner U; Gieß RM; Scheel M; Behrens JR; Rasche L; Pache FC; Wenzel R; Brandt AU; Bellmann-Strobl J; Paul F; Ruprecht K; Oechtering J
    Neurology; 2019 Oct; 93(15):e1439-e1451. PubMed ID: 31501228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.
    Gasperi C; Salmen A; Antony G; Bayas A; Heesen C; Kümpfel T; Linker RA; Paul F; Stangel M; Tackenberg B; Bergh FT; Warnke C; Weber F; Wiendl H; Wildemann B; Zettl UK; Ziemann U; Zipp F; Tumani H; Gold R; Hemmer B;
    JAMA Neurol; 2019 Jul; 76(7):841-849. PubMed ID: 31034002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual.
    Durante L; Zaaraoui W; Rico A; Crespy L; Wybrecht D; Faivre A; Reuter F; Malikova I; Pommier G; Confort-Gouny S; Cozzone PJ; Ranjeva JP; Pelletier J; Boucraut J; Audoin B
    Mult Scler; 2012 May; 18(5):587-91. PubMed ID: 21965422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome.
    van der Vuurst de Vries RM; Mescheriakova JY; Runia TF; Jafari N; Siepman TA; Hintzen RQ
    JAMA Neurol; 2017 Mar; 74(3):286-292. PubMed ID: 28055081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
    Vogt MH; Teunissen CE; Iacobaeus E; Heijnen DA; Breij EC; Olsson T; Brundin L; Killestein J; Dijkstra CD
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG Index Revisited: Diagnostic Utility and Prognostic Value in Multiple Sclerosis.
    Zheng Y; Cai MT; Yang F; Zhou JP; Fang W; Shen CH; Zhang YX; Ding MP
    Front Immunol; 2020; 11():1799. PubMed ID: 32973754
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis.
    Oechtering J; Schaedelin S; Benkert P; Müller S; Achtnichts L; Vehoff J; Disanto G; Findling O; Fischer-Barnicol B; Orleth A; Chan A; Pot C; Barakovic M; Rahmanzadeh R; Galbusera R; Heijnen I; Lalive PH; Wuerfel J; Subramaniam S; Aeschbacher S; Conen D; Naegelin Y; Maceski A; Meier S; Berger K; Wiendl H; Lincke T; Lieb J; Yaldizli Ö; Sinnecker T; Derfuss T; Regeniter A; Zecca C; Gobbi C; Kappos L; Granziera C; Leppert D; Kuhle J;
    Ann Neurol; 2021 Sep; 90(3):477-489. PubMed ID: 34057235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal immunoglobulin M production: A promising high-risk marker in clinically isolated syndrome patients.
    Huss A; Abdelhak A; Halbgebauer S; Mayer B; Senel M; Otto M; Tumani H
    Ann Neurol; 2018 May; 83(5):1032-1036. PubMed ID: 29665046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.
    Ozakbas S; Cinar BP; Özcelik P; Baser H; Kosehasanoğullari G
    Clin Neurol Neurosurg; 2017 Sep; 160():27-29. PubMed ID: 28622533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
    Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H
    Front Immunol; 2019; 10():641. PubMed ID: 30984199
    [No Abstract]   [Full Text] [Related]  

  • 12. High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis.
    Castillo-Villalba J; Gil-Perotín S; Gasque-Rubio R; Cubas-Nuñez L; Carratalà-Boscà S; Alcalá C; Quintanilla-Bordás C; Pérez-Miralles F; Ferrer C; Cañada Martínez A; Tortosa J; Solís-Tarazona L; Campos L; Leivas A; Laíz Marro B; Casanova B
    Front Immunol; 2022; 13():827738. PubMed ID: 35330910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell activation marker sCD27 is associated with clinically definite multiple sclerosis in childhood-acquired demyelinating syndromes.
    Wong YYM; van der Vuurst de Vries RM; van Pelt ED; Ketelslegers IA; Melief MJ; Wierenga AF; Catsman-Berrevoets CE; Neuteboom RF; Hintzen RQ
    Mult Scler; 2018 Nov; 24(13):1715-1724. PubMed ID: 30019626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intrathecal oligoclonal and polyspecific immune response in multiple sclerosis].
    Robinson Agramonte MA; Reiber H; Dorta Contreras AJ; Hernández Díaz E
    Rev Neurol; 2001 Nov 1-15; 33(9):809-11. PubMed ID: 11784982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.
    Peng L; Bi C; Xia D; Mao L; Qian H
    Mult Scler Relat Disord; 2019 May; 30():123-128. PubMed ID: 30771578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes.
    Magraner MJ; Bosca I; Simó-Castelló M; García-Martí G; Alberich-Bayarri A; Coret F; Alvarez-Cermeño JC; Martí-Bonmatí L; Villar LM; Casanova B
    Neuroradiology; 2012 Jan; 54(1):5-12. PubMed ID: 21327771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of prognostic biomarkers in optic neuritis.
    Tejeda-Velarde A; Costa-Frossard L; Sainz de la Maza S; Carrasco Á; Espiño M; Picón C; Toboso I; Walo PE; Lourido D; Muriel A; Álvarez-Cermeño JC; Villar LM
    Eur J Neurol; 2018 Apr; 25(4):614-618. PubMed ID: 29272057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM, IgA and IgG producing cells in cerebrospinal fluid and peripheral blood in multiple sclerosis.
    Henriksson A; Kam-Hansen S; Link H
    Clin Exp Immunol; 1985 Oct; 62(1):176-84. PubMed ID: 4064372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
    Kuhle J; Disanto G; Dobson R; Adiutori R; Bianchi L; Topping J; Bestwick JP; Meier UC; Marta M; Dalla Costa G; Runia T; Evdoshenko E; Lazareva N; Thouvenot E; Iaffaldano P; Direnzo V; Khademi M; Piehl F; Comabella M; Sombekke M; Killestein J; Hegen H; Rauch S; D'Alfonso S; Alvarez-Cermeño JC; Kleinová P; Horáková D; Roesler R; Lauda F; Llufriu S; Avsar T; Uygunoglu U; Altintas A; Saip S; Menge T; Rajda C; Bergamaschi R; Moll N; Khalil M; Marignier R; Dujmovic I; Larsson H; Malmestrom C; Scarpini E; Fenoglio C; Wergeland S; Laroni A; Annibali V; Romano S; Martínez AD; Carra A; Salvetti M; Uccelli A; Torkildsen Ø; Myhr KM; Galimberti D; Rejdak K; Lycke J; Frederiksen JL; Drulovic J; Confavreux C; Brassat D; Enzinger C; Fuchs S; Bosca I; Pelletier J; Picard C; Colombo E; Franciotta D; Derfuss T; Lindberg R; Yaldizli Ö; Vécsei L; Kieseier BC; Hartung HP; Villoslada P; Siva A; Saiz A; Tumani H; Havrdová E; Villar LM; Leone M; Barizzone N; Deisenhammer F; Teunissen C; Montalban X; Tintoré M; Olsson T; Trojano M; Lehmann S; Castelnovo G; Lapin S; Hintzen R; Kappos L; Furlan R; Martinelli V; Comi G; Ramagopalan SV; Giovannoni G
    Mult Scler; 2015 Jul; 21(8):1013-24. PubMed ID: 25680984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.
    Rudick RA; Cookfair DL; Simonian NA; Ransohoff RM; Richert JR; Jacobs LD; Herndon RM; Salazar AM; Fischer JS; Granger CV; Goodkin DE; Simon JH; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munchsauer FE; O'Reilly K; Priore RL; Whitham RH
    J Neuroimmunol; 1999 Jan; 93(1-2):8-14. PubMed ID: 10378864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.